1. South Korea Stocks

  2. •

    Transportation

  3. •

    Air freight/Couriers
CJ CheilJedang Corporation

CJ CheilJedang Corporation

104,200.00
KRW
-600.00
(-0.57%)
Nov 10Next Earn
CJ CheilJedang Corporation
KRX:097955
(Korea Stock Exchange)

Recent

price

104,200.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
5,669,203
6,538,208
9,877,532
10,847,718
11,701,797
12,924,472
14,563,257
16,477,174
18,670,060
22,352,462
24,245,726
26,289,228
30,079,513
29,023,473
27,239,748
27,342,589
27,370,176
Sales/Revenue/Turnover
7.82
7
6.23
3.18
4.96
5.81
5.79
4.71
4.46
4.01
5.61
5.8
5.53
4.45
5.33
4.51
3.83
Operating Margin (%)
174,946
180,976
309,560
381,371
447,615
483,599
531,278
565,960
640,622
1,110,411
1,285,784
1,265,299
1,403,288
1,542,100
1,558,106
1,632,125
1,606,275
Depreciation Expense
683,270
301,489
254,879
116,660
91,957
189,260
275,910
370,155
875,157
152,546
685,582
612,890
595,930
385,927
132,271
-571,456
-679,388
Net Income, GAAP
22.05
31.94
26.89
43.92
43.27
30.47
33.09
29.36
28.5
43.61
33.27
26.72
35.56
23.57
56.04
365.58
- -
Effective Tax Rate (%)
12.05
4.61
2.58
1.08
0.79
1.46
1.89
2.25
4.69
0.68
2.83
2.33
1.98
1.33
0.49
-2.09
-2.48
Profit Margin (%)
-196,140
-454,633
-25,863
-3,851
-149,168
-317,232
181,460
-533,446
-1,157,970
-259,199
387,240
-190,267
38,531
24,607
-1,311,734
-1,564,203
-1,444,388
Working Capital
452,673
2,088,922
2,919,506
3,685,473
3,483,578
3,157,199
4,087,457
4,306,074
4,192,256
6,753,421
6,593,796
6,249,736
6,783,092
6,482,180
5,802,989
6,161,395
6,737,405
LT Debt
2,879,478
4,696,474
5,221,035
4,812,579
4,949,880
5,385,233
6,060,477
6,143,853
7,308,212
9,481,480
10,166,439
10,806,800
11,529,023
11,779,942
12,226,876
11,551,203
11,969,899
Total Equity
7.74
4.32
4.61
1.86
3.04
4.73
4.72
4.2
4.12
2.88
4.59
5.51
4.91
4.28
2.71
-13.87
- -
Return on Invested Capital (%)
16.82
4.79
3.28
2.57
1.46
2.27
2.67
3.63
7.02
1.95
4.06
2.65
2.86
2.63
0.59
-8.58
- -
Return on Capital (%)
29.33
10.85
8.97
3.99
3.14
6.19
8.44
10.93
21.49
3.16
13.52
10.78
9.27
5.56
1.77
-7.67
-9.08
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
5,368,491
5,545,313
5,900,179
LT Borrowings
4,339,814
4,928,344
4,766,292
LT Finance Leases
1,821,581
1,973,917
1,971,113
Preferred Equity and Hybrid Capital
6,637
6,637
6,637
Shares Outstanding
- -
- -
- -
Market Capitalization
- -
- -
- -

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
8,869,093
9,036,492
8,967,160
Cash, Cash Equivalents & STI
1,386,145
2,242,589
1,731,600
Accounts Receivable, Net
2,919,045
3,128,984
3,107,455
Inventories
2,181,887
2,648,918
2,848,541
Total Current Liabilities
10,433,296
10,078,101
10,411,548
Payables & Accruals
- -
- -
- -
ST Debt
5,368,491
5,545,313
5,900,179
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.33%
2.68%
-5.53%
Free Cash Flow
197.99%
330.49%
-34.65%
Net Income, GAAP
-16.31%
-129.27%
-532.03%
Sales/Revenue/Turnover
8.09%
2.71%
0.38%
Total Cash Common Dividend
20.3%
14.08%
35.49%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7,215,961
7,238,675
7,414,278
7,490,168
27,239,748
2025
6,706,018
6,720,381
7,439,500
5,457,442
27,342,589
2026
7,111,120
7,362,113
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Grab Holdings Limited (NASDAQ:GRAB)
Eternal Limited (NSE:ETERNAL)
United Parcel Service, Inc. (NYSE:UPS)
DoorDash, Inc. (NASDAQ:DASH)
Swiggy Limited (NSE:SWIGGY)
FedEx Corporation (NYSE:FDX)
Business
CJ Cheiljedang Corporation engages in the food and biotechnology industries, operating primarily in South Korea and internationally. It offers a comprehensive range of products including home meal replacements; meat and fishery processing; seasoning and sauces; sweeteners, flour, and cooking oils; seaweed, desserts, and snacks; as well as beverages. The company is also active in biotechnology with products such as amino acids, green proteins, enzymes, plant nutrition and health solutions, specialty biomaterials, microbiome-based drug development for genetic infection diseases, and alternative and cultured proteins. Additionally, CJ Cheiljedang operates in animal feed, livestock, fresh meat businesses, and logistics services including transportation, storage, shipping, and loading/unloading. Founded in 1953 and headquartered in Seoul, South Korea, the company has expanded globally with operations in markets including the U.S., China, Vietnam, Japan, Europe, and more than 100 countries exporting its brands. Recent major developments include strategic investments in expanding manufacturing facilities in North America and Europe with new plants planned in South Dakota (2027) and Hungary (2026) to support growing global demand for K-food products such as kimchi, mandu, and ready-to-eat meals. Despite some operational profit challenges in the B2C sector in 2023-2024, the company has seen strong overseas sales growth, with international revenue approaching half of total sales, and has continued to innovate with new biotechnology solutions and product launches under its well-known brand Bibigo. The company also underwent leadership adjustments focused on stabilizing mid-term growth strategies in early 2024. CJ Cheiljedang operates through multiple segments including Food, Biotechnology, Feed and Care, and Logistics, with recent strategic moves emphasizing global expansion, innovation, and diversification of high-value products.